Cancer statistics, 2019
2019/01/01 by Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · 90 citations
Medicine · Economics, Econometrics and Finance · #Global Cancer Incidence and Screening #Economic and Financial Impacts of Cancer #Colorectal Cancer Screening and Detection
paper · pdf · doi:10.3322/caac.21551
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the National Center for Health Statistics. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2006-2015) was stable in women and declined by approximately 2% per year in men, whereas the cancer death rate (2007-2016) declined annually by 1.4% and 1.8%, respectively. The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with the most notable gaps for the most preventable cancers. For example, compared with the most affluent counties, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016. Some states are home to both the wealthiest and the poorest counties, suggesting the opportunity for more equitable dissemination of effective cancer prevention, early detection, and treatment strategies. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.
Cited by
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
- Cancer Statistics, 2021
- A multi-resolution model for histopathology image classification and localization with multiple instance learning
- Cancer statistics, 2022
- Cancer treatment and survivorship statistics, 2019
- Breast cancer statistics, 2019
- De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017
- Exploring the promising role of chitosan delivery systems in breast cancer treatment: A comprehensive review
- The effects of acceptance and commitment therapy on the psychological and physical outcomes among cancer patients: A meta-analysis with trial sequential analysis
- Endogenous Sex Steroid Hormones, Sex Hormone-Binding Globulin, and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies
- Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: Surgical planning with the “halo sign” and “string sign”
- The association between adherence to cancer screening programs and health literacy: A systematic review and meta-analysis
- Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: A systematic review and meta-analysis
- Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
- Three Routes to the Top
- Registration of presurgical MRI and histopathology images from radical prostatectomy via RAPSODI
- Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
- Tailoring adjuvant endocrine therapy in early breast cancer: When, how, and how long?
- Barriers and Facilitators to Lung Cancer Screening: A Physician Survey
- Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma
- Projected estimates of cancer in Canada in 2020
- Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator
- Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from 18F-FDG PET and MRI
- Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7
- Multiorgan-on-a-Chip: A Systemic Approach To Model and Decipher Inter-Organ Communication
- Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival
- A Multi-resolution Model for Histopathology Image Classification and Localization with Multiple Instance Learning
- Collagen XI alpha 1 chain, a potential therapeutic target for cancer
- Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway
- Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
- Extracting and Leveraging Nodule Features with Lung Inpainting for Local\n Feature Augmentation
- End-to-end Ultrasound Frame to Volume Registration
- Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain
- Adaptation of a deep learning malignancy model from full-field digital mammography to digital breast tomosynthesis
- EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer
- Rare metastasis in a patient with BRAF-mutated rectal cancer: choroidal metastasis – case report and literature review
- RETRACTED: High-throughput screening of ancient forest plant extracts shows cytotoxicity towards triple-negative breast cancer
- Biomembrane-derived nanoplexes for SiRNAs-pioneer innovation in delivery to lung adenocarcinoma
- Autologous stem cell transplantation meets CAR-T therapy: A synergistic strategy for B-cell lymphoma
- Epithelial characteristics of ovarian clear cell carcinoma at single-cell resolution
- The legacy of the U.S. Clean Air Act at a crossroads
- Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1
- Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC
- Emerging roles of suppressor of cytokine signaling 3 in human cancers
- Targeting cancer stem cell pathways for cancer therapy
- Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor Infiltrating Lymphocytes in Invasive Breast Cancer
- Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
- AMINN: Autoencoder-based Multiple Instance Neural Network Improves Outcome Prediction of Multifocal Liver Metastases
- Colon Polyps Detection from Colonoscopy Images Using Deep Learning
- Synthesis and In Vitro Analysis of Dual‐Functionalized Mesoporous Silica Nanoparticles for Targeted Theranosis of ER(+) Breast Cancer
- Targeting CaMKIIδ overcomes therapy resistance in acute myeloid leukemia by suppressing the STAT3/CDK6/BCL-2 survival axis
- A Hypersensitive Breast Cancer Detector
- A Mutual Bootstrapping Model for Automated Skin Lesion Segmentation and Classification
- TOPK Inhibition Enhances the Sensitivity of Colorectal Cancer Cells to Radiotherapy by Reducing the DNA Damage Response
- Pathology-Aware Generative Adversarial Networks for Medical Image Augmentation
- Denoising of computed tomography using bilateral median based autoencoder network
- Joint 2D-3D Breast Cancer Classification
- Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
- Recent advances in deep learning applied to skin cancer detection
- A Transfer Learning Based Active Learning Framework for Brain Tumor Classification
- Deep Multi-path Network Integrating Incomplete Biomarker and Chest CT Data for Evaluating Lung Cancer Risk
- Associations between antidiabetic medication use and breast cancer survival outcomes among medicare beneficiaries
- Real-time bioluminescence imaging of nitroreductase in breast cancer bone metastasis
- Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer. [europepmc]
- Burden of Gastric Cancer. [europepmc]
- Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. [europepmc]
- The role of collagen in cancer: from bench to bedside. [europepmc]
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. [europepmc]
- Cancer Progress and Priorities: Lung Cancer. [europepmc]
- Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. [europepmc]
- A rectal cancer organoid platform to study individual responses to chemoradiation. [europepmc]
- Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. [europepmc]
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. [europepmc]
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. [europepmc]
- Challenges in liver cancer and possible treatment approaches. [europepmc]
- Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164. [europepmc]
- Epigenetics of colorectal cancer: biomarker and therapeutic potential. [europepmc]
- Epidemiology of Bladder Cancer. [europepmc]
- Comprehensive review of targeted therapy for colorectal cancer. [europepmc]
- Targeting cancer stem cell pathways for cancer therapy. [europepmc]
- The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. [europepmc]
- Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. [europepmc]
- Cancer health disparities in racial/ethnic minorities in the United States. [europepmc]
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. [europepmc]
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity. [europepmc]
- Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. [europepmc]
- Estimated Projection of US Cancer Incidence and Death to 2040. [europepmc]
- Targeting TGF-β signal transduction for fibrosis and cancer therapy. [europepmc]
Related